Ten post jest także dostępny w języku: polski
In 2020, spending on oncology in Poland will amount to PLN 11.2bn, announced the Ministry of Health. In early February the Council of Ministers adopted the National Oncology Strategy. It is a comprehensive programme for fighting cancer, which assumes investment expenditures of PLN 5.1 bn between 2020 and 2023.
More than PLN 4bn increase in spending on oncology
According to the Ministry of Health, between 2013 and 2020, spending on oncology in Poland will increase by PLN 4.1bn, to PLN 11.2bn in 2020. The amount includes services provided under the so-called oncological package, but also under the following services: clinical oncology, oncological surgery, oncological gynaecology and haematology, chemotherapy, radiotherapy and drug programmes related to oncological treatment.
In addition to funds under the National Oncology Strategy (financed by the Ministry of Health), funds for oncology will also come from the National Health Fund (NFZ) and the Medical Research Agency (ABM).
Drug programmes: Increased funding and number of patients
One of the main channels of financing oncological treatment in Poland are drug programmes. Currently, there are 30 oncological drug programmes in Poland, under which 141 drugs containing 55 active substances are available.
In total, spending on oncological drugs under oncological and chemotherapy programmes amounted to PLN 2.3bn in 2019, compared to PLN 1.6bn in 2015. At the same time, the number of oncological patients under drug programmes increased to 33,000 in 2019, three times more than in 2012.